| Secondary |
| Drug Use For Unknown Indication |
41.2% |
| Product Used For Unknown Indication |
13.4% |
| Depression |
8.0% |
| Insomnia |
5.8% |
| Mental Disorder |
5.0% |
| Femur Fracture |
3.9% |
| Dementia Alzheimer's Type |
2.8% |
| Hypertension |
2.5% |
| Intentional Overdose |
2.0% |
| Drug Exposure During Pregnancy |
1.9% |
| Major Depression |
1.9% |
| Pain |
1.7% |
| Anxiety |
1.6% |
| Diabetes Mellitus |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Psychotic Disorder |
1.4% |
| Sleep Disorder |
1.1% |
| Arrhythmia |
0.9% |
| Bipolar Disorder |
0.9% |
| Hypothyroidism |
0.9% |
|
| Overdose |
7.7% |
| Vomiting |
7.7% |
| Hyponatraemia |
6.6% |
| Respiratory Failure |
6.6% |
| Transaminases Increased |
6.6% |
| Malaise |
5.5% |
| Rhabdomyolysis |
5.5% |
| Subdural Haematoma |
5.5% |
| Umbilical Cord Abnormality |
5.5% |
| Multiple Drug Overdose |
4.4% |
| Orthostatic Hypotension |
4.4% |
| Pancreatitis Acute |
4.4% |
| Pulmonary Arterial Hypertension |
4.4% |
| Somnolence |
4.4% |
| Urinary Incontinence |
4.4% |
| Extrapyramidal Disorder |
3.3% |
| Fall |
3.3% |
| Hypotension |
3.3% |
| Renal Failure |
3.3% |
| Respiratory Distress |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.1% |
| Drug Use For Unknown Indication |
14.4% |
| Depression |
12.8% |
| Hiv Infection |
9.9% |
| Anxiety |
5.4% |
| Hypertension |
3.4% |
| Insomnia |
3.2% |
| Type 2 Diabetes Mellitus |
2.8% |
| Pneumonia |
2.0% |
| Psychotic Disorder |
2.0% |
| Dementia Alzheimer's Type |
1.8% |
| Hiv Test Positive |
1.8% |
| Pain |
1.7% |
| Pulmonary Hypertension |
1.7% |
| Sleep Disorder |
1.6% |
| Hepatitis C |
1.3% |
| Osteoporosis |
1.3% |
| Schizophrenia |
1.3% |
| Essential Hypertension |
1.2% |
| Helicobacter Infection |
1.2% |
|
| Renal Failure Acute |
10.9% |
| Vomiting |
10.9% |
| Renal Failure |
7.9% |
| Ventricular Arrhythmia |
5.9% |
| Fall |
5.0% |
| Overdose |
5.0% |
| Suicide Attempt |
5.0% |
| Weight Decreased |
5.0% |
| Cholestasis |
4.0% |
| Completed Suicide |
4.0% |
| Hyponatraemia |
4.0% |
| Pemphigoid |
4.0% |
| Pruritus |
4.0% |
| Pulmonary Embolism |
4.0% |
| Syncope |
4.0% |
| Tremor |
4.0% |
| Vertigo |
4.0% |
| Depression |
3.0% |
| Loss Of Consciousness |
3.0% |
| Metabolic Acidosis |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
36.7% |
| Drug Use For Unknown Indication |
33.0% |
| Insomnia |
8.3% |
| Agitation |
5.5% |
| Depression |
5.5% |
| Bipolar I Disorder |
3.7% |
| Femur Fracture |
3.7% |
| Type 2 Diabetes Mellitus |
1.8% |
| Alcohol Detoxification |
0.9% |
| Alcohol Withdrawal Syndrome |
0.9% |
|
| Drug Interaction |
14.3% |
| Hip Fracture |
14.3% |
| Insomnia |
14.3% |
| Muscular Weakness |
14.3% |
| Femoral Neck Fracture |
7.1% |
| Hypothermia |
7.1% |
| Pneumonia Aspiration |
7.1% |
| Psychomotor Retardation |
7.1% |
| Respiratory Failure |
7.1% |
| Superinfection Lung |
7.1% |
|
